A coalition of rival labs sitting at one table, agreeing on what a good cannabis test looks like - the quiet, unglamorous work that a real market runs on.
Ask a shopper what "22% THC" means and they'll say "strong." Ask a chemist and they'll ask a follow-up question: which lab, which state, which method? The gap between those two answers is roughly the entire reason the National Cannabis Laboratory Council exists.
Here is a fact about legal cannabis that is both obvious once you hear it and slightly alarming: the same jar of flower can be tested in two states, by two accredited labs, and come back with two meaningfully different numbers. Different test panels, different sampling, different accreditation regimes. In most industries a unit of measure is a settled thing - a gallon is a gallon, a volt is a volt. Cannabis grew up legal-but-fragmented, one state at a time, and never got its settled units. What it got instead was fifty regulatory dialects and a running suspicion, occasionally justified, that labs compete partly on who reports the friendliest potency.
The National Cannabis Laboratory Council - NCLC, formed in 2021 - is the industry's attempt to fix this from the inside. It is a volunteer coalition of state-licensed cannabis laboratories, non-cannabis labs, and the science- and medical-focused ancillary businesses that orbit them. It was organized in collaboration with the law firm Perkins Coie, which is a slightly funny detail: the group best positioned to standardize chromatography turned out to need lawyers in the room. That's not incidental. Getting competitors to share data without tripping over antitrust law is a legal problem as much as a scientific one, and NCLC was built to do exactly that - carefully.
The council's stated mission is admirably plain: "to share critical data and to promote science-based national lab testing standards for cannabis products in order to facilitate interstate commerce and protect public health and consumer safety." Note the order of operations. Data first. Standards second. Commerce and safety as the payoff. That sequence is the whole strategy.
Agree on which compounds actually belong in an analysis - the cannabinoids, terpenoids, and contaminants that every credible test should look for, so results are comparable across state lines.
Standardize how samples are pulled and how tests are run. A number is only as trustworthy as the method behind it, and inconsistent sampling is where a lot of the divergence hides.
Set shared expectations for lab accreditation and proficiency testing, plus Good Manufacturing Practices - the credentialing that lets a regulator, or a buyer, believe the result.
Most trade groups exist to lobby. NCLC does something structurally harder: it convenes competitors and asks them to pool analytical data. That work is split into task groups. The Data Collection Task Group compiles measurements on cannabinoids, terpenoids, and contaminants in real commercial products - the reference evidence base the industry never had. The Publication Task Group turns that into white papers and research findings meant to move policy.
The flagship output so far is a 2022 white paper, "Standardizing Cannabis Lab Testing Nationally," which lays out the three-pillar proposal in enough detail that a regulator could actually act on it. It is not a manifesto. It reads like what it is: a technical argument that consistency is a prerequisite, not a luxury.
As of November 2023 the council's forum runs on the S3 Collective platform, which keeps the community, the studies, and the standards conversation in one place. NCLC also engages with formal standards work at ASTM International's Committee D37 - including promoting interlaboratory studies where labs run the same samples to see how closely their numbers agree.
Values illustrative. The point: without shared methods, the same product reads differently by geography.
The cannabis industry talks constantly about interstate commerce - the day products can legally cross state lines. Less discussed is the prerequisite. You cannot ship a product between markets that don't trust each other's test results. Harmonized testing isn't a nice-to-have on the road to a national market; it's the on-ramp. NCLC's bet is that the least glamorous layer - sampling protocols, proficiency tests, accreditation - is the one that has to be solved first.
For consumers, the stakes are more immediate. Contaminant testing - for pesticides, heavy metals, microbials - is a safety function, and a patchwork of standards means safety that varies by ZIP code. For operators, consistent testing removes the incentive to "lab shop" for a friendlier number, which quietly punishes the honest labs. For regulators, a ready-made, science-based framework is easier to adopt than one built from scratch fifty times over.
None of this is loud work. There is no NCLC product on a dispensary shelf. What there is instead is a white paper, a growing dataset, and a room where competitors agree to measure the same things the same way. In an industry that markets on vibes, that's a genuinely different pitch: trust built on reproducibility.
Cannabis lab scientists and operators, working with Perkins Coie, launch the coalition.
"Standardizing Cannabis Lab Testing Nationally" formalizes the three-pillar proposal.
The platform becomes NCLC's operational home for members and studies.
NCLC promotes an ASTM D8375 interlab study (ILS #1829) to member labs.
NCLC shares that ASTM's cannabis committee elected new leadership.
The law firm that helped organize NCLC in 2021 and co-authored its standardization white paper - keeping the data-sharing antitrust-clean.
Hosts NCLC's community and operations since November 2023, from member sign-ups to study coordination.
The formal cannabis standards committee NCLC engages with on interlaboratory studies and methods.
Membership spans state-licensed cannabis labs, state-licensed non-cannabis labs, and non-plant-touching scientific and medical operators. Among the industry figures aligned with the effort: Steve Albarran, co-founder and CEO of cannabis lab-software company Confident LIMS (formerly Confident Cannabis) and an active NCLC member.
NCLC's success looks like boredom - cannabis testing so consistent it stops being a story.
It was co-organized by a law firm better known for courtrooms than chromatography.
It gets rival labs to share data - carefully, inside antitrust guardrails.
Its core deliverable isn't a product you buy - it's a standard the whole industry can use.
A volunteer coalition, formed in 2021, of cannabis laboratories, scientists, and science- and medical-focused ancillary operators that promotes science-based national standards for cannabis lab testing.
It was organized in 2021 by a coalition of cannabis lab scientists and operators in collaboration with the law firm Perkins Coie.
National standards in three areas: standard test panels (which compounds to test for), sampling requirements and testing methodologies, and lab accreditation and proficiency testing.
Without them, the same product can get different results in different states, undermining consumer safety, public health, and any path to interstate commerce.
As of November 2023, the NCLC operates its forum and member community through the S3 Collective platform, continuing its data-sharing and standards advocacy work.